Thrombotic diseases, in particular cardiovascular and cerebrovascular thrombotic diseases, have become the top cause of death in the population of China, and their incidence has increased, seriously endangering human health.

China has been engaged in the R&D and manufacturing of semi-automatic coagulation analyzers for over a decade, and based on the data from the website of the NMPA, in 2024 and 2025 (as od 15 August), a total of 2 instruments from 2 manufacturers have obtained registration certificates...

The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences, today announced the nominees for the 2022 Prix Galien International Awards.

MDxHealth reported after the close of the market Wednesday a 21 percent increase in first quarter 2022 sales.

Qiagen on Tuesday afternoon reported strong first quarter revenues that blew by Wall Street estimates, driven by growth in its molecular diagnostics business.

Exact Sciences reported after the close of the market on Tuesday that its first quarter revenues rose 21 percent year over year.

On April 27, Autobio, BSBE, Easy Diagnosis, Medicalsystem, Dian Diagnostics, Hybribio and Kingmed released 2022 Q1 report.

Wondfo, BGI, Leadman, Sinocare, ACROBiosystems, NanoMicro released 2022 Q1 Report

Illumina said on Monday that it has entered into a collaboration with Germany's Hannover Medical School to implement whole-genome sequencing in critically ill children suspected of having a genetic or rare disease.

Laboratory Corporation of America said Friday that it is collaborating with Getlabs phlebotomy service to provide at-home blood draws and specimen collection.

On April 24, Shanghai Universal Biotech's released its 2021 annual report. The report shows that in 2021, the company will achieve operating income of CNY 1.110 billion, a year-on-year increase of 30.69%.

Johnson & Johnson (NYSE: JNJ) today announced results for first-quarter 2022.